FibroGen

21.02.2025 • News

FibroGen Sells Chinese Subsidiary to AstraZeneca

US-based biotechnology company FibroGen announced the sale of its China subsidiary to AstraZeneca for approximately $160 million.

02.08.2013 • News

AstraZeneca Warns Of Higher Costs As Drug Sales Slide

19.04.2013 • News

Astellas, GSK Vie to Make 'High Altitude' Anaemia Pill

Top-Feature

Ecocool GmbH

Transport Logistic: Ecocool Presents Packaging Solutions for Pharmaceutical Transports

Evonik Industries AG

Maximize the Potential of Spent Hydroprocessing Catalysts

IMCD Deutschland GmbH

Fostering Innovation and Collaboration

Interview

Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.